The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth by Munjoma, Marshall W et al.
RESEARCH ARTICLE Open Access
The prevalence, incidence and risk factors of
herpes simplex virus type 2 infection among
pregnant Zimbabwean women followed up nine
months after childbirth
Marshall W Munjoma1,2*, Edith N Kurewa1,2, Munyaradzi P Mapingure2,3, Grace V Mashavave1, Mike Z Chirenje1,
Simbarashe Rusakaniko3, Akhtar Hussain4, Babill Stray-Pedersen2
Abstract
Background: Herpes simplex virus type 2 (HSV-2) is the leading cause of genital ulcer disease worldwide. The virus
can be transmitted to neonates and there are scarce data regarding incidence of HSV-2 among women in
pregnancy and after childbirth. The aim of this study is to measure the incidence and risk factors for HSV-2
infection in women followed for 9 months after childbirth.
Methods: Pregnant women were consecutively enrolled late in pregnancy and followed at six weeks, four and
nine months after childbirth. Stored samples were tested for HSV-2 at baseline and again at nine months after
childbirth and HSV-2 seropositive samples at nine months after childbirth (seroconverters) were tested
retrospectively to identify the seroconversion point.
Results: One hundred and seventy-three (50.9%) of the 340 consecutively enrolled pregnant women were HSV-2
seronegative at baseline. HSV-2 incidence rate during the 10 months follow up was 9.7 (95% CI 5.4-14.4)/100 and
18.8 (95% CI 13.9-26.1)/100 person years at risk (PYAR) at four months and nine months after childbirth respectively.
Analysis restricted to women reporting sexual activity yielded higher incidence rates. The prevalence of HSV-2
amongst the HIV-1 seropositive was 89.3%. Risk factors associated with HSV-2 seropositivity were having other
sexual partners in past 12 months (Prevalence Risk Ratio (PRR) 1.8 (95% CI 1.4-2.4) and presence of Trichomonas
vaginalis (PRR 1.7 95% CI 1.4-2.1). Polygamy (Incidence Rate Ratio (IRR) 4.4, 95% CI 1.9-10.6) and young age at
sexual debut (IRR 3.6, 95% CI 1.6-8.3) were associated with primary HSV-2 infection during the 10 months follow
up.
Conclusions: Incidence of HSV-2 after childbirth is high and the period between late pregnancy and six weeks
after childbirth needs to be targeted for prevention of primary HSV-2 infection to avert possible neonatal
infections.
Background
Herpes Simplex Virus type 2 (HSV-2) infection is a
sexually transmitted infection (STI) which is recognized
as the most common cause of genital ulcer disease
worldwide [1,2]. Many people that are infected with
HSV-2 are unaware of their infectious status in spite of
symptoms [3]. The risk of acquiring HIV is greater with
recent HSV-2 infections than with chronic infections
[4]. HSV-2 prevalence, which is high in sub-Saharan
Africa, occurs more frequently in women than in men
[5] and is mainly transmitted through heterosexual con-
tact. In the USA and in Norway about 2% and 2.6%
respectively of susceptible women acquired HSV infec-
tion during pregnancy and those that acquire the infec-
tion close to term are at high risk of transmitting the
virus from cervix or lower genital tract to their babies
during vaginal delivery with the most serious
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consequences for the neonates [6,7]. Transplacental pas-
sage of virus is however rare and thus HSV-2 infection
is not associated with stillbirths [8].
Earlier studies in Zimbabwe reported an HSV-2 preva-
lence of 42.2% amongst women of childbearing age [9],
prevalence and incidence rates of 39.8% and 6.2/100
PYAR respectively amongst male factory workers [10].
The major public health importance of HSV-2 relates to
its potential role in enhancing HIV transmission. The
population attributable risk for HIV-1 due to HSV-2 in
Zimbabwe is estimated at 65% [11] and for that reason
HSV-2 infection should be recognized as a much greater
public health problem than is currently the case. There
are currently no studies in the sub-Saharan Africa to
measure HSV-2 incidence rates and risk factors amongst
women who have recently given birth. The postpartum
period is a time when women are potentially more sus-
ceptible to STIs due to the traumatic nature of the vagi-
nal delivery [12] and subsequent lack of oestrogen
during lactation. Furthermore there may be unprotected
sex among couples that ignore the dual protection
against pregnancy and STIs offered by condoms and use
them for contraceptive purposes only since part of this
period is often considered “safe” from falling pregnant.
The purpose of this study is to measure the incidence
rate and prevalence of HSV-2 among women followed 9
months after childbirth.
Methods
Between April and September 2002, 354 consecutive
pregnant women seeking routine antenatal services from
three randomly selected primary health care clinics in
two of Harare’s peri-urban high density suburbs were
invited to participate in the study on average four weeks
before childbirth. Five (5) of the women refused to par-
ticipate, six (6) agreed but did not turn up for any of
the scheduled visits and three (3) only turned up at the
six week visit but no samples were taken. This analysis
was based on the 340 women (173 HSV-2 uninfected
and 167 HSV-2 infected) that came at all the scheduled
visits.
The women were enrolled from the national program
for the prevention of mother to child transmission of
HIV at around 36 weeks of gestation and were followed
up to investigate the role of STIs and micronutrients on
mother to child transmission of HIV. The women were
enrolled if they were pregnant, willing to undergo HIV
counseling and testing, had no history of complications
with the current pregnancy and were planning to deliver
at any of the three randomly selected clinics. HSV-2 was
tested at baseline and samples that were HSV-2 serone-
gative were tested for HSV-2 seroconversion at nine
months after childbirth. Samples that were seropositive
at nine months were tested retrospectively at four
months and six weeks to identify the last seronegative
and first seropositive visit. The study participants were
encouraged to bring their male partners for counseling,
testing and treatment of curable STIs. All the partici-
pants consented to long term storage and future testing
of their samples. All participants provided written
informed consent and the study was approved by both
the Medical Research Council of Zimbabwe and the
Norwegian Ethical Committee.
At baseline female interviewers administered a stan-
dardized questionnaire to record socio-demographic,
reproductive history and sexual behavior information. A
gynaecological examination was done by a trained clini-
cian during which a high vaginal swab for testing of Tri-
chomonas vaginalis and yeast cells was collected
together with a blood sample for testing HSV-2, HIV-1
and syphilis. A structured questionnaire was adminis-
tered at follow up visits mainly to capture information
relating to the period since the last visit.
Antibodies to HSV-2 at baseline were identified using
the HerpeSelect 2 ELISA IgG (Focus Diagnostics) and
the results were interpreted according to the manufac-
turers’ specifications while all the follow up tests were
interpreted using an index cut-off value of 3.5. Antibo-
dies to HIV-1 were identified using two rapid test kits
in parallel, “Determine” (Abbott Diagnostics) and Ora-
quick (Orasure technologies). Screening for syphilis was
done using a non-specific rapid plasma reagin (RPR)
and all positives were confirmed using Treponema Palli-
dum Hemaglutination Assay (TPHA), both manufac-
tured by Randox Laboratories. A wet mount prepared
from freshly collected vaginal fluid was mixed with nor-
mal saline and examined using a compound microscope
for the presence of Trichomonas vaginalis and yeast
cells.
Statistical analyses
Data were analyzed with the Statistical Package for
Social Sciences (SPSS) version 16.0 (SPSS, IL, USA) and
STATA version 10.0, Texas, USA. Incidence, as a per-
centage and expressed as person years at risk (PYAR)
was calculated for everyone and restricted analysis was
done on participants that reported having resumed
sexually activity after childbirth. Time of infection was
assumed to have occurred mid point between last nega-
tive and first positive test. Because the HSV-2 preva-
lence was high we calculated prevalence risk ratios
(PRR) using log binomial regression with the generalized
linear model (glm) function in STATA. Poisson regres-
sion and the robust option of estimating variance-covar-
iance matrix was used to calculate incidence rate ratios
(IRR) for factors associated with HSV-2 acquisition over
the ten months follow up period. Multivariate regression
with cut off set at p = 0.25 was performed in STATA to
investigate independent predictors of HSV-2
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seropositivity. Statistical significance was set at p < 0.05
and Fisher’s exact p-values were used where appropriate.
Results
Three hundred and forty (340) pregnant women agreed
to participate and had samples collected during the 10
months follow-up period from enrolment to nine
months after childbirth. The median age of the partici-
pants at enrollment was 23.0 years with an interquartile
range of 20-28 years; median number of pregnancies
(including current pregnancy) was 2.0 and median num-
ber of living children was 1.0. The majority of the
women (97.9%) were married but of note were the 9%
(95% CI 6.0-12.1) who were in polygamous marriages.
Although the participants were encouraged to bring
their male partners only 43 males (12.6%) attended.
The prevalence of HSV-2 and HIV-1 amongst partici-
pants at enrollment was 49.1% and 24.7% respectively
whilst the prevalence of HSV-2 among the 43 male part-
ners was 46%. The prevalence of syphilis as confirmed
by TPHA was 0.3%. Table 1 shows the characteristics
that are associated with prevalent HSV-2 infection.
Being in a polygamous marriage (PRR 1.4, 95% CI 1.1-
1.9), having other sexual partners in the past 12 months
(PRR 1.8, 95% CI 1.4-2.4), having ever used contracep-
tives (PRR 1.5, 95% CI 1.2-2.0), being infected with Tri-
chomonas vaginalis (PRR 1.7, 95% CI 1.4-2.1) and HIV-
1 (PRR 2.5 95% CI 2.1-3.0) all have statistically signifi-
cant association with HSV-2 prevalence in univariate
analysis.
In multivariate analysis HIV positivity and infection
from Trichomonas vaginalis remained as independent
significant risk factors for HSV-2 seropositivity with risk
estimates of 2.4(1.9-3.0) and 1.7(1.3-2.2) respectively.
Figure 1 shows distribution of HSV-2 seropositivity by
age group among the HIV-1 infected (black diamond)
and HIV uninfected (black square) participants. As
observed the prevalence of HSV-2 among the HIV-1
infected was above 80% across all age groups. Of note is
the relatively low HSV-2 prevalence among the HIV
uninfected (35.0%) especially among those aged >34
years. The overall prevalence of HSV-2 amongst HIV-1
infected participants was 89.3% compared to 35.8%
amongst the HIV-1 uninfected, PRR 2.5(2.1-2.9).
During the 10-month follow-up period, 20 of the 167
seronegative women acquired HSV-2, seven (7) was
detected at four months and 13 at nine months after
childbirth. At six weeks three (3) had an index value >
than 1.1 but < 3.5 and were therefore considered not
seroconverted at that visit but were confirmed and
included in the four months visit. Table 2 shows the
incidence rate of HSV-2 seroconversion per 100 PYAR
for all seronegative mothers and for those that reported
being sexually active at different times after childbirth.
From four months to nine months after childbirth, sexu-
ally active mothers reported a higher incidence rate of
21.2/100 PYAR (table 2). The cumulative incidence rate
during the 10 months was 13.9/100 PYAR. Nineteen
(19) of these seroconverters (11.6%) were among the
164 HIV-1 negative women while one seroconverter
occurred among the 9 (11.1%) HIV-1 positive women, p
= 0.955. Most of the seroconverters (80%) were below
25 years of age.
Table 3 shows the risk factors for acquisition of HSV-
2 within the 10 months follow up and of note is the sta-
tistically significant risk of women in polygamous mar-
riages compared to those in monogamous marriages
(IRR 4.4 95% CI 1.9-10.6). Low age at sexual debut was
significantly associated with acquisition of HSV-2 (IRR
3.6 95% CI (1.6-8.3). Over 95% of the women in each
group cleansed the vagina with water. Mean age (SD)
difference for non-seroconverters and their partners and
seroconverters and their partners were 5.5 (4.7) and 8.7
(5.8) respectively, p = 0,008. IRR for seroconverting per
unit increase in age difference between the women and
their partners was 1.07 (95% CI 1.0 - 1.1).
HSV-2 infected women were on average significantly
older than HSV-2 uninfected women, mean ages 25.5
and 22.9 years respectively, p < 0.001. Similarly male
partners of HSV-2 infected women were on average sig-
nificantly older than male partners of HSV-2 uninfected
women, mean ages 31.9 and 28.4 years respectively, p <
0.001. Mean age difference for the partnership between
HSV-2 infected and HSV-2 uninfected were 6.4 and 5.5
years respectively, p = 0.026.
Discussion
Our results showed a cumulative HSV-2 incidence of
13.9/100 PYAR at 9 months after childbirth, which is
higher than previously reported figures in literature
[9,10]. If the risk of acquiring HIV-1 is greater amongst
HSV-2 primary cases compared to chronic cases [4]
then our data demonstrate that HSV-2/HIV-1 seronega-
tive women that acquire HSV-2 postpartum have the
highest risk of acquiring HIV-1. This high HSV-2 inci-
dence may be due to a combination of two factors;
firstly this group of women may be using condoms
purely for contraceptive purposes and stopped during
pregnancy and breastfeeding period and secondly, vagi-
nal delivery is an event that leaves the birth canal trau-
matized [12] thereby making women more vulnerable to
STIs if they have unprotected sex. The low syphilis pre-
valence observed could be due to the fact that syphilis
screening is standard of care for pregnant women in
Zimbabwe.
The risk factors associated with acquisition of HSV-2
after giving birth were polygamous marriage and young
age at sexual debut. In Zimbabwe the hazard ratio for
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Table 1 Univariate analysis of risk factors for HSV-2 positivity among pregnant women
Variable n HSV-2
Positive
Prevalence
Risk Ratio
(PRR) (95% CI)
p value
Total 340 167(49.1%)
Age group
<20 yrs 65 25(38.5%) Referent
20-24 yrs 135 55(40.7%) 1.1(0.7-1.5) 0.760
25-29 yrs 76 47(61.8%) 1.6(1.1-2.3) 0.009
30-34 yrs 47 33(70.2%) 1.8(1.3-2.6) 0.001
>34 yrs 17 7(41.2%) 1.1(0.6-2.0) 0.836
Marital Status*
Single 7 2(28.6%) Referent
Married 330 163(49.4%) 1.7(0.5-5.6) 0.362
Polygamy
No 303 144(47.5%) Referent
Yes 31 21(67.7%) 1.4(1.1-1.9) 0.010
Educational level
>Primary 279 131(47.0%) Referent
≤Primary 61 36(59.0%) 1.3(1.0-1.6) 0.066
Age at sexual debut*
≥16 298 145(48.7%) Referent
<16 38 20(52.6%) 1.1(0.8-1.5) 0.634
Other sexual partners past
12 months
No 329 157(47.7%) Referent
Yes 8 7(87.5%) 1.8(1.4-2.4) < 0.001
Ever used contraceptives*
No 136 51(37.5%) Referent
Yes 203 116(57.1%) 1.5(1.2-2.0) 0.001
Ever used intravaginal herbs*
No 283 136(48.1%) Referent
Yes 56 31(55.4%) 1.2(0.9-1.5) 0.295
Clinical genital ulcer*
No 282 131(46.5%) Referent
Yes 8 6(75.0%) 1.6(1.1-2.5) 0.025
Clinical genital warts*
No 270 125(46.3%) Referent
Yes 25 15(60.0%) 1.3(0.9-1.8) 0.141
Trichomonas vaginalis
Negative 296 134(45.3%) Referent
Positive 38 30(79.0%) 1.7(1.4-2.1) < 0.001
Yeasts*
Absent 204 102(50.0%) Referent
Present 130 62(47.7%) 1.0(0.8-1.2) 0.682
HIV-1 serostatus at
enrolment
Negative 256 92(35.9%) Referent
Positive 84 75(89.3%) 2.5(2.1-3.0) < 0.001
*denominator less than 340.
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HIV among HSV-2 seroconverting women is 8.6 (95%
CI 4.3-17.1) compared with 4.4 (95% CI 2.7-7.2) among
women with chronic HSV-2 [11]. With a fertility rate of
3.8 children [13] a high HSV-2 incidence after birth
implies that each time a woman gives birth she goes
through a period when the risk of acquiring HSV-2 is
very high. Furthermore, the risk of neonatal herpes is
greatest in a pregnant woman who acquires HSV infec-
tion late in pregnancy [6,14] due to lack of circulating
maternal antibodies that usually provide the fetus with
passive immunity [15]. Our participants, particularly the
three that were below an index value of 3.5 at six weeks,
could have been infected late in pregnancy and thus
were at risk of transmitting HSV-2 to their unborn
infants. However there was no evidence of clinical neo-
natal herpes infection in these children.
There was no difference between rates of acquisition
of HSV-2 amongst HIV-1 infected (11.1%) compared to
HIV-1 unifected (11.7%). Several other studies have
demonstrated the role of HSV-2 in the transmission of
HIV-1 [11,16,17]. However, a recent study which tested
stored samples collected in the early 80’s showed that
the prevalence of HSV-2 in this part of the world was
already widespread before the HIV epidemic and has
not been greatly affected by the HIV-1 epidemic [18].
People that are co-infected have more frequent HSV-2
reactivations which last longer [19] and tend to shed
more herpes virus than HIV-1 uninfected [20].
The prevalence for HSV-2 and HIV-1 was 49.4%
(44.1-54.7) and 24.9% (20.2-29.5) respectively. Contrast-
ing prevalence of two infections that share essentially
the same risk factors is a result of the combination of
the infectiousness of HSV-2 and the high mortality asso-
ciated with HIV-1 disease [21] in regions where avail-
ability of HIV/AIDS treatment is limited. HSV-2 targets
the epithelial cells during the infectious process [22]
while HIV-1 targets mainly CD4+ lymphocytes, which
can mostly be reached via lesions in the mucosa. In
2007 about 67% of the 32.9 million people living with
HIV-1 were in the sub-Sahara where 75% of all HIV
related deaths occurred [21]. In Zimbabwe the popula-
tion attributable fraction of HIV due to HSV-2 is about
65% [11] and as a result HSV-2 should be recognized as
a public health problem leading to design and imple-
mentation of HSV-2 prevention strategies such as health
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Figure 1 Prevalence of HSV-2 amongst HIV infected and uninfected pregnant women according to age groups.
Table 2 HSV-2 seroconversion at different time points after childbirth
Period observed Enrollment - 4 months pp*
(5 months)
4-9 months pp*
(5 months)
Enrollment - 9 mths pp*
(10 months)
Seroconverters, n 7 13 20
Seronegative women, n 173 166 173
Person-time 72.1 person-years 69.2 person-years 144.2 person-years
Incidence per
100 PYAR* (95%CI) 9.7 (5.4-14.3) 18.8 (13.9-26.1) 13.9 (9.1-19.6)
Sexually active mothers, n (%) 144 (83.3%) 147 (88.4%) 153 (88.4)%
Person-time 60.0 person-years 61.3 person-years 127.5 person-years
Incidence per 100 PYAR* in sexually
active mothers (95%CI)
11.7 (6.5-16.9) 21.2 (16.2-294) 15.7 (10.9-22.8)
*PYAR - Person years at risk, *pp - postpartum
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Table 3 Univariate analysis of risk factors for seroconverting within 9 months after childbirth
Variable n HSV-2 seroconversion Incidence Risk ratio (IRR)
(95%CI)
P value
Total 173 20 (11.7)
Age group
<20 yrs 40 6(15.0%) Referent
20-24 yrs 81 10(12.4%) 0.8(0.3-12.1) 0.685
25-29 yrs 29 1(3.5%) 0.2(0.0-1.8) 0.164
30-34 yrs 13 2 (15.4%) 1.0(0.2-4.5) 0.973
>34 yrs 10 1(10.0%) 0.7(0.1-5.0) 0.692
Marital status*
Single 5 0 Referent
Married 167 20(12.0%) Incalculable 1.000**
Polygamy
No 160 16(10.0%) Referent
Yes 9 4(44.4%) 4.4(1.9-10.6) 0.001**
Educational level
>Primary school 149 17(11.4%) Referent
= <Primary school 24 3(12.5%) 1.1(0.3-3.5) 0.877**
Age at sexual debut (years)*
>16 years 153 14 (9.2%) Referent
≤16 years 18 6 (33.3%) 3.6(1.6-8.3) 0.002
Abstain from sex during
pregnancy*
Yes 40 4 (10.0%) Referent
No 131 16 (12.2%) 1.2 (0.4-3.5%) 0.706**
Resumed sex after delivery*
Six weeks after birth
No 88 11(12.6%) Referent
Yes 40 6 (15.0%) 1.2 (0.5-3.0) 0.699
Four months after birth
No 10 1 (10.0%) Referent
Yes 74 10 (13.5%) 1.4 (0.2-9.6) 0.763**
Nine months after birth
No 12 0 (0) Referent
Yes 131 12 (9.2) Incalculable 0.273**
Cleanse the vagina*
No 7 0 (0) Referent
Yes 166 20 (12.1) Incalculable 0.329**
Ever used intravaginal herbs*
No 147 16 (10.9%) Referent
Yes 25 4 (16.0%) 1.5 (0.5-4.0) 0.461**
Clinical genital ulcer*
No 151 18 (11.3%) Referent
Yes 2 0 Incalculable 0.615**
Clinical genital warts*
No 146 15 (10.4%) Referent
Yes 9 2 (22.2%) 2.2 (0.6-8.1) 0.251**
*denominator less than 173. ** Fisher’s Exact p values.
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education about the role of HSV-2 and how it enhances
HIV infectiousness.
When stratified by age the prevalence of HSV-2 was
seen to be high amongst the HIV-1 infected (black dia-
mond) across all age groups compared to HIV-1 unin-
fected (black square) participants (Figure 1).
Furthermore HSV-2 seropositive women were about
three times more likely to be HIV-positive than HSV-2
negative women. The disparities in HSV-2 prevalence
between the HIV-1 infected and uninfected indicate an
increased susceptibility of the HSV-2 seropositive to
HIV-1 infection [9,23]. Because of the bidirectional asso-
ciation between HIV and HSV-2 it follows that HIV
infected/HSV-2 uninfected are also at risk of acquiring
HSV-2 [10,24]. If these women acquire HSV-2 infection
late in pregnancy their risk of transmitting the virus to
the infant intrapartum is high [6,25]. In such cases, if
the couple is HSV-2 discordant, we recommend that
they avoid sexual contact late in pregnancy. If avoiding
sexual contact late in pregnancy is difficult then we sug-
gest prophylactic treatment with acyclovir to HIV
infected/HSV-2 uninfected pregnant women to avoid
neonatal herpes [26], especially if their partners are
HSV-2 infected.
The majority of the participants had their sexual debut
before the age of 20. Young women have the highest
risk of acquiring STIs including HIV-1 infection [27].
Early sexual debut and polygamy were significantly asso-
ciated with acquisition of HSV-2 after childbirth. The
Southern African region is currently using the “One-
Love” approach to discourage people from having multi-
ple concurrent partners(MCP) [28]. Multiple concurrent
partnerships are observed when older men have sexual
relationships with young girls and vice versa. Polygamy
should be considered as having MCP and should be
discouraged.
Age plays an important role in the transmission of
STIs. In this study we found that HSV-2 infected parti-
cipants as well as their partners were significantly older
than the HSV-2 uninfected participants and their part-
ners. Age difference between women and their husbands
remains a silent driver of the HIV-1 epidemic as the
older men have more exposure than the young women,
resulting in a disproportionate prevalence of STIs
between young men and women [27,29,30].
Although the study participants were encouraged to
bring their male partners for counseling, testing and
treatment of curable STIs only 43 (12.6%) came. In sub-
Saharan Africa reproductive health research place a dis-
proportionate emphasis on women and ignore the
equally important role of men [31]. Poor attendance by
men in this study (12.8%) should encourage researchers
to come up with strategies to involve men to participate
in reproductive health research.
Conclusions
Incidence of HSV-2 after childbirth is high and there-
fore the period between late pregnancy and six weeks
after childbirth needs to be targeted for prevention of
primary HSV-2 infection to avert possible neonatal
infections. Ideally HSV-2-discordant couples must be
identified and advised to avoid sexual contact late in
pregnancy. Furthermore effort must be made to include
men in reproductive health research.
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